SCHEMBL18797709

SCHEMBL18797709

O=C(Cl)c1c(Br)ccc(F)c1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
ALOX15 P16050 1/20 0.36
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.33
HPGD P15428 1/20 0.33
P2RX7 Q99572 1/20 0.33
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32
KMT2A Q03164 1/20 0.32
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
CES2 O00748 1/20 0.31
CES1 P23141 1/20 0.31
NOTUM Q6P988 1/20 0.31
DAO P14920 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
HTR2B P41595 1/20 0.31
KIF11 P52732 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18797741 0.84 NOTUM (0.37) ALDH1A1ALOX15NPC1RAB9ASMN1; SMN2
SCHEMBL1165021 0.83 ALDH1A1 (0.44) ALDH1A1ALOX15P2RX7GAACES2
SCHEMBL8675762 0.79 ALDH1A1 (0.52) ALDH1A1ALOX15P2RX7GAACES2
SCHEMBL18797706 0.78 CA12 (0.40) ALDH1A1NPC1RAB9AHPGDLMNA
SCHEMBL28052874 0.78 ALDH1A1 (0.38) ALDH1A1ALOX15NPC1RAB9ASMN1; SMN2
SCHEMBL15809161 0.73 CES2 (0.52) ALDH1A1ALOX15LMNAGAAKMT2A
SCHEMBL28172626 0.73 KCNQ3 (0.37) ALDH1A1ALOX15RAB9ACES2DAO
SCHEMBL14660959 0.72 DPP4 (0.36) ALOX15NPC1RAB9ASMN1; SMN2HPGD
SCHEMBL16122077 0.72 ALDH1A1 (0.41) ALDH1A1ALOX15CES2CES1
SCHEMBL27630874 0.71 ALDH1A1 (0.46) ALDH1A1ALOX15GAAKMT2ACES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3368535-B1 HETEROARYL SUBSTITUTED BENZOIC ACIDS AS RORGAMMAT INHIBITORS AND USES THEREOF MERCK SHARP & DOHME (US) 2020-12-02 EP disclosed
EP-3368535-B1 HETEROARYL SUBSTITUTED BENZOIC ACIDS AS RORGAMMAT INHIBITORS AND USES THEREOF MERCK SHARP & DOHME (US) 2020-12-02 EP disclosed
US-10584121-B2 Heteroaryl substituted benzoic acids as RORgammaT inhibitors and uses thereof MERCK SHARP & DOHME CORP. (US) 2020-03-10 US disclosed
US-20190194186-A1 HETEROARYL SUBSTITUTED BENZOIC ACIDS AS RORgammaT INHIBITORS AND USES THEREOF MERCK SHARP & DOHME LLC 2019-06-27 US disclosed
EP-3368535-A1 HETEROARYL SUBSTITUTED BENZOIC ACIDS AS RORGAMMAT INHIBITORS AND USES THEREOF Merck Sharp & Dohme Corp. (US) 2018-09-05 EP disclosed
WO-2017075185-A1 HETEROARYL SUBSTITUTED BENZOIC ACIDS AS RORGAMMAT INHIBITORS AND USES THEREOF MERCK SHARP & DOHME CORP. (US) 2017-05-04 WO disclosed
WO-2017075185-A1 HETEROARYL SUBSTITUTED BENZOIC ACIDS AS RORGAMMAT INHIBITORS AND USES THEREOF MERCK SHARP & DOHME CORP. (US) 2017-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194186-A1 HETEROARYL SUBSTITUTED BENZOIC ACIDS AS RORgammaT INHIBITORS AND USES THEREOF RORB, RORA, RORC ALDH1A1 321/4885ALOX15 1864/4885NPC1 600/4885
US-10584121-B2 Heteroaryl substituted benzoic acids as RORgammaT inhibitors and uses thereof RORB, RORA, RORC ALDH1A1 321/4885ALOX15 1864/4885NPC1 600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.